Addus HomeCare Reports Strong Q4 & Full-Year 2025 Results with Double-Digit Revenue and EPS Growth
ADUS sits 32% above its 52-week low of $88.96.
Summary
Addus HomeCare announced strong fourth quarter and full-year 2025 financial results, featuring double-digit growth in net service revenues, adjusted net income per diluted share, and adjusted EBITDA, driven by its personal care segment and strategic acquisitions.
Key Events · Earnings and Guidance · ADUS
-
Strong Q4 2025 Financial Performance
Net service revenues increased 25.6% to $373.1 million, adjusted net income per diluted share rose 28.3% to $1.77, and adjusted EBITDA grew 33.3% to $50.3 million year-over-year.
-
Record Full-Year 2025 Results
Full-year net service revenues reached a new record of $1.42 billion, up 23.2% from 2024, with adjusted EBITDA increasing 28.3% to $180.0 million and adjusted net income per diluted share at $6.23.
-
Key Segment Growth and Rate Increases
The personal care business, accounting for 76.6% of Q4 revenues, achieved 6.3% organic growth. The company also noted significant rate increases in Texas (9.9%) and Illinois (3.9%) for its personal care services. Hospice care organic revenue grew 16.0%.
-
Robust Cash Flow and Acquisition Strategy
Net cash provided by operating activities was $18.8 million for Q4 and $111.5 million for the full year 2025, enabling debt reduction and supporting an ongoing strategy of strategic acquisitions, with three completed in 2025.
Analysis · ADUS · Industrial Applications And Services
Addus HomeCare delivered robust financial performance for both the fourth quarter and full year 2025, significantly exceeding prior year results across key metrics. The company's personal care segment continues to be a primary growth driver, bolstered by favorable rate increases in major markets like Texas and Illinois, which are expected to positively impact future revenues. Strong cash flow generation is enabling debt reduction and supporting an active acquisition strategy, indicating a healthy financial position and a clear path for continued expansion. While home health saw negative organic growth, its smaller contribution to overall revenue minimizes its impact on the otherwise strong results.
How filings like this one have moved
In the 30 days to Sep 15, 2026, 35.6% of the 1100 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.43%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, ADUS was trading at $117.63 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $2.2B. The 52-week trading range was $88.96 to $124.44. This filing was assessed with positive market sentiment and an importance score of 8 out of 10.